All data are based on the daily closing price as of May 12, 2026
t

TCI

8436.TWO
3.79 USD
-0.05
-1.30%

Overview

Last close
3.79 usd
Market cap
417.56M usd
52 week high
5.05 usd
52 week low
3.38 usd
Target price
5.09 usd

Valuation

P/E
13.847
Forward P/E
13.5685
Price/Sales
1.8694
Price/Book Value
1.7268
Enterprise Value
339.23M usd
EV/Revenue
1.5303
EV/EBITDA
5.7781

Key financials

Revenue TTM
223.39M usd
Gross Profit TTM
100.20M usd
EBITDA TTM
55.84M usd
Earnings per Share
0.27 usd
Dividend
N/A usd
Total assets
470.69M usd
Net debt
N/A usd

About

TCI Co., Ltd., an original design manufacturer company, engages in the manufacturing, wholesale, and retail of health foods and cosmetics products in Taiwan, Mainland China, the United States, and internationally. The company offers liquid and solid supplements; immunity products; functional probiotics; basic nutrition; detox slimming; body health; sports nutrition supplement products; laundry detergents; hand sanitizers; and functional snacks, which includes, jelly, bars, chocolates, and gummies. It also provides skin care products, such as facial, body sheet, eye, and lip masks; essence; functional sprays; creams; and gels, as well as turnkey services. In addition, the company is involved in the wholesale of chemical production; research and development of biotechnology and genetics; trading health foods for pets; and selling medical machinery. TCI Co., Ltd. was incorporated in 1980 and is headquartered in Taipei, Taiwan.
  • Symbol
    8436.TWO
  • Exchange
    TWO
  • Isin
    TW0008436007
  • Country
    Taiwan
  • Sector
    Consumer Defensive
  • Industry
    Household & Personal Products
  • CEO
    Mr. Yung-Hsiang Lin
  • Headquarter
    Taipei
  • Web site
    https://www.tci-bio.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top